Last updated: April 24, 2026

Application No. 19/342,035

Untitled Application

Unknown

Filed

1600

Examiner

OGUNBIYI, OLUWATOSIN A

Art Unit

1645

Tech Center

IPSEN BIOPHARM LIMITED

Assignee

Ipsen Biopharm Limited

OA Round

1 (Non-Final)

This examiner grants 63% of cases after interview

— +42.9% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.

Based on 914 resolved cases, 2023–2026

Examiner Intelligence

OGUNBIYI, OLUWATOSIN A View full profile →

Grants 63% of resolved cases

Career Allow Rate

579 granted / 914 resolved

+3.3% vs TC avg

Strong +43% interview lift

Without

With

+42.9%

Interview Lift

resolved cases with interview

Typical timeline

3y 1m

Avg Prosecution

48 currently pending

Career history

962

Total Applications

across all art units

Statute-Specific Performance

§101

5.5%

-34.5% vs TC avg

§103

26.4%

-13.6% vs TC avg

§102

24.0%

-16.0% vs TC avg

§112

26.3%

-13.7% vs TC avg

Black line = Tech Center average estimate • Based on career data from 914 resolved cases

Prosecution Timeline

1600

Application Filed

Nov 14, 2025

Non-Final Rejection (current)

Precedent Cases

Applications granted by this same examiner with similar technology

17/631,709

Patent 12606612

MULTIVALENT DNA ANTIBODY CONSTRUCTS AND USE THEREOF

2y 5m to grant Granted Apr 21, 2026

16/894,684

Patent 12599549

TREATMENT OF MODERATE TO VERY SEVERE GLABELLAR LINES AND LATERAL CANTHAL LINES

2y 5m to grant Granted Apr 14, 2026

18/243,159

Patent 12601745

DIAGNOSTICS OF PERIODONTITIS

2y 5m to grant Granted Apr 14, 2026

18/531,284

Patent 12594309

BIFIDOBACTERIA FOR TREATING DIABETES AND RELATED CONDITIONS

2y 5m to grant Granted Apr 07, 2026

17/910,852

Patent 12589124

BIFIDOBACTERIUM LONGUM

2y 5m to grant Granted Mar 31, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.

Prosecution Projections

1-2

Expected OA Rounds

63%

Grant Probability

99%

With Interview (+42.9%)

3y 1m

Median Time to Grant

Low

PTA Risk

Based on 914 resolved cases by this examiner. Grant probability derived from career allow rate.